And what did Imatron mgmt say about this as it was happening? Were they screaming manipulation by GE? Had the device already obtained FDA approval when the company was bought out? If so, then don't you think it's possible that they were having trouble selling the device in the competitive medical device marketplace?
Companies don't need to illegally manipulate a competitor's stock to hurt that competitor's business prospects when there are plenty of perfectly legal machinations to utilize in the sales and marketing space.
This "DNDN stock is being manipulated by Big Pharma" theory is a Looney Tunes theory that posters should be too embarrassed about to have their msg board handles associated with publically.
Market Data 
Markets 
AI
